Theradiag SA

ALTHE · PA · Healthcare / Medical Devices

0.594EUR-0.04 (-6.31%)

Price History

Full chart

Market Stats

Previous Close0.634

Open0.635

Day Range0.592 – 0.648

52-Week Range0.402 – 0.93

Volume220.78K

Market Cap48.85M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.09

Dividend Yield0.00%

Beta0.42

50-Day Avg0.6603

200-Day Avg0.6131

About

Theraclion SA provides therapeutic ultrasound technology for seamless vein care. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient's skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Martin Deterre
Employees40
Headquarters244, avenue Pierre Brossolette, Malakoff, France, 92240, France
Websitehttps://www.theraclion.com

Leadership

Mr. Martin DeterreGM & CEO
Julie VeisseireAdministrative and Financial Director & CFO
Ms. Alexandra RocherVice President of Operations
Jérémie AnquezVP Research & Chief Scientific Officer
Thibault Le NormandDirector of Sales, Marketing & Applications
Dr. Michel Nuta M.D.VP of Veins & Chief Medical Officer

Financials

Income Statement

Currency: EUR	2001-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	2.00K	11.41M	212.96K	937.42K	3	76.50K	819.68K	1.60M	1.98M	2.82M	1.94M	2.78M	744.00K	1.48M	1.24M	1.82M	830.00K	1.19M
Growth (%)	-	+570350.00%	-98.13%	+340.19%	-100.00%	+2549800.00%	+971.52%	+94.89%	+23.64%	+43.00%	-31.33%	+43.56%	-73.28%	+99.06%	-16.58%	+47.49%	-54.45%	+42.89%
Cost of Revenue	-	7.50M	995.70K	1.11M	1.78M	2.19M	2.79M	4.82M	4.68M	5.23M	4.47M	6.80M	4.55M	6.02M	4.29M	2.90M	8.01M	7.39M
Gross Profit	-	-	-782.74K	-170.42K	-1.78M	-2.12M	-1.97M	-3.22M	-2.70M	-2.40M	-2.53M	-4.02M	-3.81M	-4.54M	-3.05M	-1.08M	-7.18M	-6.21M
Gross Margin	-	-	-367.55%	-18.18%	-59460900.00%	-2769.38%	-239.97%	-201.44%	-136.91%	-85.06%	-130.32%	-144.29%	-511.69%	-306.55%	-246.91%	-59.29%	-865.42%	-523.52%
Operating Expense	-	-	1.50M	1.91M	1.86M	2.43M	2.99M	4.02M	4.78M	4.70M	4.45M	504.00K	479.00K	197.00K	3.26M	2.07M	-223.00K	165.00K
Operating Income	-	-	-2.29M	-2.08M	-3.65M	-4.55M	-4.96M	-7.24M	-7.49M	-7.10M	-6.98M	-4.52M	-4.29M	-4.74M	-6.31M	-3.15M	-6.96M	-6.37M
Operating Margin	-	-	-1073.45%	-222.28%	-121539033.33%	-5943.50%	-605.01%	-453.28%	-379.09%	-251.32%	-359.79%	-162.39%	-576.08%	-319.85%	-510.54%	-173.09%	-838.55%	-537.44%
EBITDA	-	-	-1.98M	-1.73M	-3.20M	-4.06M	-4.66M	-6.73M	-7.17M	-6.74M	-6.62M	-4.48M	-4.15M	-4.40M	-5.74M	-4.49M	-5.92M	-5.99M
EBITDA Margin	-	-	-928.81%	-184.36%	-106802033.33%	-5308.49%	-568.86%	-421.15%	-363.00%	-238.48%	-341.53%	-160.91%	-557.74%	-297.35%	-464.63%	-246.25%	-712.77%	-505.06%
Net Income	-	-	-1.91M	-1.68M	-3.07M	-4.11M	-4.63M	-6.41M	-6.54M	-6.22M	-6.14M	-3.79M	-3.90M	-3.76M	-4.96M	-3.68M	-5.76M	-5.69M
Net Income Margin	-	-	-899.23%	-178.69%	-102425200.00%	-5373.82%	-565.35%	-401.43%	-330.93%	-220.38%	-316.84%	-136.21%	-524.87%	-253.88%	-401.83%	-201.68%	-693.61%	-479.76%
R&D	473.00K	-	-	-	206.00K	1.23M	1.73M	2.60M	3.20M	3.80M	3.60M	3.60M	2.10M	3.82M	4.30M	-	-	-
R&D as % of Total Revenue	23650.00%	-	-	-	6866666.67%	1601.37%	211.30%	162.76%	162.02%	134.55%	185.63%	129.31%	282.26%	257.93%	348.05%	-	-	-
Interest Expense	0	0	26.27K	2.79K	32.18K	126.39K	188.28K	163.75K	240.46K	234.91K	274.00K	256.64K	330.00K	136.00K	44.06K	31.45K	21.54K	162.00K
Interest Expense % of Total Revenue	0.00%	0.00%	12.33%	0.30%	1072666.67%	165.23%	22.97%	10.25%	12.18%	8.32%	14.13%	9.22%	44.35%	9.18%	3.57%	1.73%	2.59%	13.66%

Balance Sheet

Currency: EUR	2001-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	150.00K	6.58M	3.91M	2.31M	3.20M	2.94M	8.28M	9.26M	14.71M	13.77M	9.56M	10.51M	10.55M	11.83M	13.94M	18.66M	11.47M	12.51M
Total Liabilities	812.00K	3.69M	2.63M	2.19M	2.90M	6.75M	5.51M	8.50M	9.13M	10.30M	10.10M	10.59M	13.78M	13.10M	13.40M	13.01M	11.47M	15.10M
Total Equity	-	2.88M	1.28M	120.37K	297.60K	-3.80M	2.77M	756.80K	5.58M	3.47M	-531.92K	-79.73K	-3.24M	-1.27M	544.87K	5.65M	-114	-2.59M
Cash	17.00K	2.49M	2.07M	32.05K	1.27M	376.60K	2.74M	1.92M	1.90M	4.86M	907.77K	1.40M	2.31M	2.46M	2.49M	7.82M	4.17M	1.88M
Total Debt	-	-	2.27M	1.55M	2.09M	5.58M	3.96M	5.01M	661.39K	673.30K	52.97K	424.44K	10.61M	2.39M	2.51M	1.95M	1.30M	5.09M
Net Debt	-	-	193.74K	1.52M	818.45K	5.20M	1.22M	-1.92M	-1.90M	-4.86M	-907.77K	-975.56K	1.74M	-99.00K	21.14K	-5.86M	-2.88M	3.21M

Cash Flow

Currency: EUR	2001-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-	-	-	-952.02K	-2.66M	-4.04M	-5.18M	-4.98M	-7.97M	-6.79M	-4.73M	-3.69M	-3.32M	-3.88M	-5.27M	-2.48M	-2.91M	-7.16M
Investing Cash Flow	341.00K	-	-	-350.76K	-410.23K	-231.40K	-493.19K	-824.78K	-16.12K	-176.35K	-1.11M	-316.39K	-192.55K	-524.46K	-739.63K	-213.52K	-188.00K	-414.00K
Financing Cash Flow	229.00K	1.49M	103.00K	-175.49K	3.76M	3.38M	9.54M	5.28M	11.21M	4.92M	1.89M	4.52M	4.41M	4.56M	6.03M	7.99M	-545.00K	6.78M
Capital Expenditure	11.00K	178.00K	252.00K	673.00K	430.00K	432.71K	493.19K	866.27K	192.83K	184.98K	163.46K	131.63K	131.93K	148.22K	322.68K	112.29K	102.00K	0
Free Cash Flow	-	-	-	-952.02K	-2.66M	-4.47M	-5.67M	-5.84M	-8.16M	-6.97M	-4.89M	-3.82M	-3.45M	-4.03M	-5.59M	-2.60M	-3.01M	-7.16M
FCF to OCF	-	-	-	100.00%	100.00%	110.72%	109.53%	117.40%	102.42%	102.73%	103.46%	103.56%	103.97%	103.82%	106.13%	104.52%	103.50%	100.00%

Earnings

Report Date	Sep 22, 2017	Oct 26, 2017	Apr 10, 2018	Sep 19, 2018	Nov 5, 2018	Mar 21, 2019	May 29, 2019	Sep 16, 2019	Nov 27, 2019	Jan 27, 2020	May 19, 2020	Sep 23, 2020	Dec 11, 2020	Mar 22, 2021	Jun 2, 2021	Jul 12, 2021	Dec 1, 2021	Mar 21, 2022	Apr 1, 2022	Jul 27, 2022	Nov 30, 2022	Mar 20, 2023	Apr 28, 2023	Jul 31, 2023	Oct 11, 2023	Oct 26, 2026
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-
EPS Actual	-0.09	-0.09	-0.60	-0.01	0.00	-0.08	0.00	0.07	0.00	-0.03	0.00	-0.03	0.00	0.00	0.00	-0.01	0.00	-0.05	0.00	0.00	0.00	0.00	-0.03	0.07	0.00	-
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	Pre-market	-	-	-	Pre-market	After-hours	-	After-hours	-	After-hours	After-hours	After-hours	Pre-market	After-hours	-	After-hours	-	-	Pre-market	After-hours	-	-	After-hours	After-hours	After-hours	After-hours

Key Statistics & Ratios

Market Cap48.85M

Enterprise Value51.92M

Trailing P/E0.00

Forward P/E0.00

Price / Sales101.76

Price / Book3.21

EPS-0.09

Book Value-0.043

Revenue (TTM)480.00K

Gross Profit (TTM)-4.29M

EBITDA-8.44M

Profit Margin0.00%

Operating Margin-591.54%

Return on Equity-203.90%

Return on Assets-40.38%

Shares Outstanding73.78M

Shares Float32.35M

Beta0.42

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Stock Splits

Jul 26, 2016367:350